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Cardiovascular diseases (CVD) are on the rise in Sub‑Saharan Africa, and a large proportion of the 
adult population is thought to suffer from at least one cardiometabolic risk factor. This study assessed 
cardiometabolic risk factors and the contribution of nutrition‑related indicators in Gambian women. 
The prevalence and co‑existence of diabetes (elevated glycated hemoglobin (HbA1c ≥ 6.5%) or 
prediabetes (HbA1c ≥ 5.7% to < 6.5%), hypertension (systolic blood pressure ≥ 140 mmHg or diastolic 
blood pressure ≥ 90 mmHg), obesity (body mass index (BMI) ≥ 30.0) and inflammation (C‑reactive 
protein (CRP) > 3 mg/L or alpha‑1‑acid glycoprotein (AGP) > 1 g/L) and the contribution of nutrition 
related and socioeconomic indicators were measured in non‑pregnant women 15–49 years of age in 
the Gambia using data from a nationally representative cross‑sectional stratified survey. Nationally, 
54.5% (95% CI: 47.4, 61.4) of 1407 women had elevated HbA1c. Of these, 14.9% were diabetic and 
85.1% were prediabetic. Moreover, 20.8% (95% CI 17.8, 20.0) of 1685 women had hypertension, 11.1% 
(95% CI 9.0, 13.7) of 1651 were obese and 17.2% (95% CI 5.1, 19.6) of 1401 had inflammation. At 
least one of the aforementioned cardiometabolic risk factor was present in 68.3% (95% CI 63.0, 73.1) 
of women. Obesity increased the risk of hypertension (aRR 1.84; 95% CI 1.40, 2.41), diabetes (aRR 
1.91; 95% CI 1.29, 2.84), elevated HbA1c (aRR 1.31; 95% CI 1.14, 1.51) and inflammation (aRR 3.47; 
95% CI 2.61, 4.61). Inflammation increased the risk of hypertension (aRR 1.42; 95% CI 1.14, 1.78). 
Aging increased the risk of hypertension, obesity and inflammation. Further, inadequate sanitation 
increased the risk for diabetes (aRR 1.65; 95% CI 1.17, 2.34) and iron deficiency increased the risk of 
elevated HbA1c (aRR 1.21; 95% CI 1.09, 1.33). The high prevalence of cardiometabolic risk factors and 
their co‑existence in Gambian women is concerning. Although controlling obesity seems to be key, 
multifaceted strategies to tackle the risk factors separately are warranted to reduce the prevalence or 
minimize the risk of CVD.
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More than half of the yearly global deaths can be attributed to non-communicable diseases (NCDs)1 and between 
1990 and 2017, the total number of disability adjusted life years (DALYs) lost due to NCDs increased by 67% 
and the contribution of NCDs to the total burden of disease in Sub-Saharan Africa (SSA) increased by 60%. For 
the majority of NCDs, this drastic increase is solely attributable to the growing and aging population. However, 
this is not true for diabetes mellitus, certain cancers and certain cardiovascular diseases (CVD), which exhibit 
age-standardized increasing  rates2 and account for large parts of NCD attributable  deaths1. The World Health 
Organization has defined 9 voluntary targets in prevention and control of NCDs to be attained by 2025, includ-
ing the reduction in mortality from CVD, diabetes, cancer, and chronic respiratory diseases and a halt in the 
rise in the prevalence of diabetes and  obesity3. NCDs are alarmingly on the rise in SSA, mainly driven by an 
increasing incidence of cardiovascular risk  factors4. SSA currently experiences an epidemiological transition, 
which is characterized by an increase in the prevalence of  NCDs2 and a persistently-high incidence of the main 
infectious diseases, such as  malaria5,  tuberculosis6, and  HIV7. It is estimated that NCDs will have superseded 
communicable diseases as the major cause of death by  20304. To date, the majority of NCDs in SSA are CVDs, 
but data on NCDs and their risk factors in SSA countries are scarce, rendering a comprehensive assessment 
difficult, albeit indispensable for the development of evidence-based policies and the implementation of health 
 programs4. Globally, hypertension, diabetes, obesity and inflammation are major cardiometabolic risk  factors8,9 
and a risk factor assessment of NCDs has shown that most adults in SSA are exposed to at least one risk  factor2. 
Hypertension is mainly caused by excessive consumption of alcohol, smoking, physical inactivity, unhealthy diet, 
overweight and obesity, and high salt  intake1, whereas diabetes mellitus type 2 is mainly driven by overweight 
and  obesity10,11. In 2019, globally, 463 million people were diabetic, 19 million of whom were in SSA. Projections 
estimate that these numbers will increase, so that by 2045 about 700 million and 47 million people will suffer from 
diabetes globally and in SSA,  respectively12. Moreover, inflammation is recognized as a critical cardiometabolic 
risk factor for CVD, particularly for  atherosclerosis13. As NCDs are posited to cause morbidity and mortality 
in The  Gambia14, a current and thorough investigation of their prevalence and associated risk factors is war-
ranted. This study thus assessed the prevalence, intra-individual co-existence and determinants of established 
cardiometabolic risk factors, such as diabetes mellitus, pre-diabetes, hypertension, inflammation, and obesity 
in a national sample of non-pregnant women as part of The Gambia National Micronutrient Survey  201815.
Results
The study sample comprised 1703 non-pregnant women with a mean age of 28.5 ± 9.4 years, of whom 1446 
provided a blood sample. Data on diabetes and pre-diabetes were available from 1407 women, data on inflam-
mation from 1401, data on obesity from 1651 and data on hypertension from 1685. More details on the survey 
population is presented  elsewhere16. The co-existence of obesity, hypertension, elevated HbA1c and inflammation 
in the same woman is shown in Fig. 1. In all, 70.1% (95% CI 65.7, 74.2) of women suffered from at least one of 
the investigated cardiometabolic risk factors. Presence of only one risk factor was found in 43.3% (95% CI 38.8, 
48.0) of women, with one-third of women found with elevated HbA1c. Co-existence of two of the risk factors 
was found in 17.1% (95% CI 14.5, 20.0) of women, whereas 7.9% (95% CI 6.3, 9.8) were affected by three risk 
factors, and 1.8% (95% CI 1.0, 3.4) of women had all four combined.
The prevalence of women with diabetes, elevated HbA1c, obesity, hypertension and any inflammation as well 
as the bivariate associations between those risk factors and demographic indicators are presented in Table 1. 
Candidate predictors retained in the multivariate models included age and household sanitation for diabetes; 
woman’s education and household sanitation for elevated HbA1c; age, woman’s education, residence, local gov-
ernment authority, and wealth quintile for hypertension; age, local government authority, and wealth quintile 
for obesity, and age for any inflammation.
Table 2 presents the bivariate associations between the risk factors and nutrition and health indicators in the 
non-pregnant women. As iron deficiency anemia (IDA) is a composite variable of anemia and iron deficiency 
(ID), multivariate models excluded IDA if either anemia and/or ID were already included. The following indica-
tors were included as potential predictors into the multivariate model: nutritional status and minimum dietary 
diversity for diabetes; nutritional status, anemia, ID, and physical activity for elevated HbA1c; nutritional status 
and physical activity for hypertension; minimum dietary diversity and ID for obesity; and nutritional status, 
IDA and minimum dietary diversity for any inflammation.
Table 3 presents the bivariate associations between the different risk factors. Significant associations were 
found between obesity and diabetes, obesity and hypertension, and obesity and inflammation, but not between 
obesity and elevated HbA1c. Inflammation was significantly associated with diabetes, hypertension, and obesity; 
the association between inflammation and elevated HbA1c was close to significant.
When looking at AGP and CRP separately, HbA1c was significantly associated with AGP, but not CRP. 
Overall, 68.6% of women with high AGP had elevated HbA1c, but only 52.7% of women with normal AGP had 
elevated HbA1c (p < 0.001); whereas 58.5% of women with elevated CRP had high HbA1c compared to 53.2% 
of women with normal CRP (p = 0.27). The prevalence of hypertension was higher in women with elevated CRP 
(33.9% vs. 15.8%, p < 0.0001) and in women with elevated AGP, albeit without statistical significance (30.9% 
vs. 18.2%, p = 0.08). Moreover, the prevalence of elevated AGP (26.1% vs. 7.9%, p < 0.0001) and CRP (58.5% vs. 
15.3%, p < 0.0001) was higher in obese women compared to women without obesity.
Multivariate analyses (Table 4) showed that overweight and obese women had a higher risk to develop diabetes 
compared to the normal weight. Further, living in households with inadequate sanitation increased the risk for 
diabetes compared to living in households with adequate sanitation.
Overweight and obesity also increased the risk for elevated HbA1c compared to normal weight. Further, 
women with ID had an increased risk for elevated HbA1c compared to those without. On the other hand, attend-
ing secondary school slightly reduced the risk of elevated HbA1c.
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Increasing age as well as increasing weight resulted in higher risks for hypertension. Also, women with inflam-
mation had a higher risk to develop hypertension compared to those without. Contrary, the risk for hypertension 
continuously decreases with increasing levels of education.
The risk for obesity strongly increased with increasing age and household wealth.
For inflammation, the risk was higher in women with overweight and obesity compared to normal weight 
and for older women compared to young ones.
Discussion
Our study found that more than 2 out of 3 Gambian women had at least one of the investigated cardiometabolic 
risk factors. This finding is concerning and suggests that NCDs are widespread in The Gambia and that policies 
and programs to address NCDs should be further developed and accelerated. As part of its 2013–2020 Global 
NCD Action Plan, WHO aims to reduce hypertension as well as diabetes and  obesity3. The current WHO national 
NCD targets for The Gambia are limited to a reduction in tobacco and alcohol use, and no targets have been 
formulated for hypertension, obesity and diabetes 17. Our results demonstrate that The Gambia should strongly 
consider revising its NCD targets as NCDs are common despite smoking and alcohol consumption being very 
 uncommon18.
Obesity. One potential entry point to reducing NCDs in The Gambia is through obesity reduction. Although 
still relatively low in The  Gambia16, the prevalence of obesity increased by more than 50% in 5 years, from 7.3% 
in  201319 to 11.1% in  201820. Despite the relatively low obesity prevalence, our analysis found repeated and 
significant associations between obesity and the other investigated cardiometabolic risk factors, indicating that 
obesity is key to the development of other metabolic disorders in The Gambia. The direction of the association 
between obesity and other investigated factors has been well  documented21,22  : in obese people, the secretion of 
several adipokines and cytokines, which are involved in various metabolic processes including carbohydrate and 
lipid metabolism compounds is increased and often associated with low grade inflammation and the develop-
ment of metabolic disorders such as type 2 diabetes and certain  CVD23,24. Further, according to the International 
Diabetes Federation (IDF), obesity is playing a central role in the development of the metabolic  syndrome25, a 
clustering of related metabolic disturbances which have been shown to increase the risk of CVD and type 2 dia-
betes, such as prediabetes, hypertension and visceral  obesity26,27. Thus, we can presume that if obesity is reduced, 
cases of elevated HbA1c, diabetes, hypertension, and inflammation will also be reduced.
Figure 1.  Coexistence of obesity (BMI ≥ 30.0), hypertension (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg), 
elevated HbA1c (≥ 5.7%) and inflammation (CRP > 3 mg/L and/ or AGP > 1 g/L) in the same woman (includes 
only the 1391 women with data on all cardio metabolic risk factors); grey = proportion of women without risk 
factor, blue = proportion of women with one risk factor, green = proportion of women with two risk factors, 
orange = proportion of women with three risk factors, purple = proportion of women with four risk factors.
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Diabetes and pre‑diabetes. The last estimate from 1997 reported less than 1% of the adult population 
of The Gambia being  diabetic28, which is a mere fraction of what was found in 2018. The high prevalence of 
diabetes and also the large proportion of individuals who exhibit prediabetes are of major concern, particularly 
since prediabetic individuals have a substantially increased risk to develop  diabetes29. Furthermore, a series of 
subclinical abnormalities, such as increased blood levels of low-density lipoprotein cholesterol or triglycerides, 
as well as obesity and hypertension are often present in prediabetic  patients30. Meta-analyses found that predia-
Table 1.  Associations between cardio metabolic risk factors and demographic indicators in non-pregnant 
women, The Gambia, 2018. Note: All N’s reflect the total number of subjects with valid data for each condition. 
N’s for each sub-group analysis vary slightly. a Diabetes defined as glycated hemoglobin (HbA1c) ≥ 6.5% and 
elevated HbA1c as ≥ 5.7% b Hypertension defined as systolic blood pressure of ≥ 140 mmHg and/or a diastolic 
blood pressure of ≥ 90 mmHg. c Obesity defined as body mass index (BMI) of ≥ 30 kg/ m2. d Percentages 
weighted for non-response and survey design. e CI = confidence interval, adjusted for cluster and stratified 
sampling design. f Chi-square p-value < 0.05 indicates that the proportion in at least one subgroup is 
statistically significant. g Composite variable of toilet type and if toilet facilities are shared with non-household 
members; Adequate Sanitation = flush or pour flush toilet or pit latrine with slab not shared with another 
household; Inadequate sanitation = open pit, bucket latrine, hanging toilet/latrine, no facility, bush, field. h Any 
inflammation defined as CRP > 3 mg/L and/or AGP > 1 g/L.
Characteristic
Diabetesa Elevated  HbA1ca Hypertensionb Obesityc Any  Inflammationh
(N = 1407) (N = 1407) (N = 1685) (N = 1651) (N = 1401)
%d (95% CI)e %d (95% CI)e %d %d %d (95% CI)e %d (95% CI)e
Age in years (p-valuef)  < 0.05 0.40  < 0.0001  < 0.0005  < 0.0001
15–19 4.4 (2.3, 8.1) 50.4 (42.4, 58.5) 9.5 (6.6, 13.5) 2.1 (0.7, 6.3) 7.2 (4.7, 11.0)
20–24 7.9 (4.9, 12.5) 52.1 (43.4, 60.6) 12.2 (5.7, 24.3) 4.1 (1.8, 9.3) 14.5 (10.8, 19.1)
25–29 8.8 (4.5, 16.8) 51.0 (39.1, 62.9) 13.1 (8.7, 19.2) 4.7 (2.3, 9.3) 20.6 (12.6, 31.9)
30–34 5.7 (3.0, 10.5) 53.1 (40.5, 65.4) 21.0 (14.7, 29) 16.1 (9.0, 26.9) 22.8 (15.6, 32.1)
35–39 12.5 (6.8, 22.0) 56.7 (43.3, 69.1) 28.3 (17.9, 41.7) 15.1 (10.4, 21.6) 35.0 (28.8, 41.8)
40–44 5.2 (2.0, 12.8) 63.9 (52.9, 73.6) 44.7 (29.4, 61) 32.2 (24.7, 40.8) 45.8 (35.1, 57.0)
45–49 18.9 (8.8, 36.0) 65.2 (41.4, 83.3) 53.8 (40.5, 66.5) 2.1 (0.7, 6.3) 45.3 (32.8, 58.5)
Woman’s education (p-valuef) 0.21  < 0.05  < 0.005 0.50 0.14
Never at school 11.4 (5.5, 22.0) 62.1 (54.6, 69.0) 29.1 (22.5, 36.7) 12.2 (9.0, 16.4) 26.4 (20.9, 32.6)
Primary school 8.1 (4.7, 13.5) 59.7 (50.9, 68.0) 19.4 (14.9, 24.9) 10.7 (7.4, 15.4) 22.0 (14.4, 32.2)
Lower Secondary 5.2 (2.7, 9.6) 49.8 (39.6, 59.9) 16.7 (9.6, 27.4) 12.7 (7.3, 21.4) 18.8 (11.9, 28.5)
Upper Secondary 3.4 (1.3, 8.7) 35.7 (23.8, 49.7) 10.0 (6.5, 15.2) 6.3 (3.5, 11.1) 15.8 (11.6, 21.1)
Higher 7.7 (2.6, 20.5) 53.5 (29.3, 76.2) 11.0 (5.3, 21.5) 10.8 (4.3, 24.4) 32.5 (21.7, 45.5)
Residence (p-valuef) 0.22 0.58 0.06 0.15 0.18
Urban 7.2 (4.2, 12.0) 53.6 (44.0, 63.0) 18.8 (15.6, 22.6) 12.3 (9.6, 15.6) 23.9 (21.8, 26.2)
Rural 10.3 (7.7, 13.7) 56.6 (51.4, 61.7) 25.5 (19.8, 32.1) 8.3 (5.2, 13.0) 20.2 (15.9, 25.3)
Local Gov’t Authority (p-valuef) 0.14 0.18  < 0.005 0.09 0.23
Banjul 13.6 (7.4, 23.8) 57.2 (47.1, 66.7) 28.0 (22, 34.9) 17.1 (12.3, 23.2) 28.8 (23.3, 35)
Kanifing 7.8 (4.8, 12.4) 45.1 (34.5, 56.1) 11.5 (8.1, 16.1) 15.8 (11.6, 21.2) 26.7 (22.6, 31.2)
Brikama 7.1 (3.1, 15.8) 57.7 (43.2, 71.1) 20.0 (15.5, 25.3) 11.4 (7.8, 16.4) 21.4 (18.6, 24.6)
Mansakonko 2.8 (1.5, 5.3) 41.2 (31.3, 51.7) 24.3 (20.5, 28.6) 5.1 (3.8, 7.0) 24.5 (17.1, 33.7)
Kuntaur 19.8 (11.6, 31.8) 67.6 (45.7, 83.8) 12.6 (7.6, 20) 2.7 (1.0, 7.3) 14.8 (7.5, 26.9)
Kerewan 12.9 (7.7, 20.8) 63.3 (54.4, 71.3) 31.4 (18.1, 48.7) 9.6 (5.8, 15.4) 28.3 (18.7, 40.3)
Janjanbureh 8.9 (4.1, 18.5) 56.8 (49.9, 63.4) 18.6 (14, 24.3) 6.8 (4.2, 10.9) 21.6 (16, 28.4)
Basse 5.4 (2.9, 10.0) 49.9 (42.2, 57.6) 29.2 (21.7, 38.1) 10.6 (5.4, 19.9) 20.1 (13.7, 28.5)
Wealth quintile (p-valuef) 0.57 0.21 0.08  < 0.005 0.56
Poorest 11.9 (7.6, 18.4) 62.2 (54.5, 69.3) 23.6 (17.3, 31.4) 3.9 (2.5, 5.9) 18.8 (13.1, 26.2)
Second 7.8 (4.1, 14.5) 57.4 (43.8, 69.9) 19.9 (13.7, 28) 8.9 (6.7, 11.7) 21.8 (15.4, 29.8)
Middle 7.5 (2.8, 18.6) 60.1 (47.7, 71.3) 25.5 (19.7, 32.4) 13.0 (8.6, 19.2) 24.1 (17.5, 32.2)
Fourth 5.9 (3.3, 10.4) 54.9 (41.6, 67.5) 16.9 (13.2, 21.4) 12.2 (7.9, 18.3) 21.7 (16.6, 27.8)
Wealthiest 7.6 (4.3, 12.9) 39.3 (20.9, 61.4) 16.2 (12.4, 21) 15.7 (10.3, 23.3) 26.5 (21.4, 32.3)
Household sanitation g 
(p-valuef)  < 0.01 0.09 0.86 0.21 0.14
Inadequate 10.5 (7.1, 15.1) 59.8 (55.0, 64.5) 21.0 (16.5, 26.4) 10.0 (7.5, 13.2) 20.5 (17.4, 24)
Adequate 5.3 (3.2, 8.5) 48.2 (35.7, 60.9) 20.5 (16.7, 24.9) 12.4 (9.1, 16.7) 25.6 (21.2, 30.7)
Total 8.1 (5.7, 11.3) 54.5 (47.4, 61.4) 20.9 (17.9, 34.3) 11.4 (9.3, 14.0) 22.9 (20.9, 25.0)
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betes also favors the development of  CVD31,32, although it is unclear if this effect is caused by the aforementioned 
abnormalities or prediabetes  itself33.
A strong increase in diabetes prevalence can be observed in SSA in  general34 and in Western Africa in 
 particular35. The 2019 Diabetes Atlas published by the International Diabetes Federation estimates that the dia-
betes prevalence in SSA is about 4%, with country-specific prevalence rates ranging from 2.1 to 7.1% (10). These 
estimates are slightly lower than the estimates from our study. However, the current true prevalence of diabetes in 
Gambian adults is uncertain, as our study did not include older women, who have a higher prevalence of diabetes 
than younger  women36, and it did not include men, who may have a lower prevalence of diabetes than  women37. 
One potential reason for the slightly higher diabetes prevalence found in The Gambia compared to those reported 
from other SSA countries could be the use of HbA1c as a biomarker for diabetes. ID and IDA can cause elevation 
in glycated hemoglobin by altering the erythrocyte turnover and lead to an over-estimation of the prevalence of 
prediabetes and  diabetes38. We find the prevalence of diabetes in women with ID 2 percentage points, and with 
IDA 3 percentage points higher—albeit not significantly—than in iron replete women. Yet, the prevalence of 
elevated HbA1c was significantly higher among women with ID and IDA compared to women without.
Although we found that obesity was significantly associated with an increased risk of elevated HbA1c and 
diabetes, about 55% of diabetic women in our study had low to normal BMIs. This finding is similar to other 
studies, that found that a larger proportion of diabetic persons in SSA have low to normal BMI compared to 
diabetic persons in Europe and North America, which might be related to the high prevalence of diabetes in SSA 
due to impaired insulin secretion rather than insulin resistance as it is the case in Europe and North  America39.
Further, our results indicate that inadequate sanitation was associated with diabetes. Prolonged exposure to 
inadequate sanitation can cause environmental  enteropathy40, which has been associated with the development 
of diabetes via inflammatory and non-inflammatory  pathways41,42.
Table 2.  Associations between cardio metabolic risk factors and nutrition and health indicators in non-
pregnant women, The Gambia, 2018. a Diabetes defined as glycated hemoglobin (HbA1c) ≥ 6.5% and 
elevated HbA1c as ≥ 5.7% b Hypertension defined as systolic blood pressure of ≥ 140 mmHg and/or a diastolic 
blood pressure of ≥ 90 mmHg. c Underweight, overweight, and obesity defined as body mass index (BMI) 
of < 18.5 kg/ m2, ≥ 25- < 30 kg/ m2 and ≥ 30 kg/ m2, respectively. d Percentages weighted for non-response 
and survey design. e CI = confidence interval, adjusted for cluster and stratified sampling design. f Chi-square 
p-value < 0.05 indicates that the proportion in at least one subgroup is statistically significantly. g Minimum 
dietary diversity was met if the number of food groups consumed the day prior to the interview was ≥ 5 (25). 
h Anemia defined as hemoglobin < 120 mg/L. I Iron deficiency defined as serum ferritin < 15 µg/l; iron deficiency 
anemia defined as low serum ferritin and low hemoglobin. j Vitamin A insufficiency defined as retinol binding 
protein < 1.05 μmol/L. k Any inflammation defined as CRP > 3 mg/L and/or AGP > 1 g/L.
Characteristic
Diabetesa Elevated  HbA1ca Hypertensionb Obesityc Any  Inflammationk
%d (95% CI)e %d (95% CI)e %d (95% CI)e %d (95% CI)e %d (95% CI)e
Nutritional status c (p-valuef)  < 0.005  < 0.05  < 0.0001  < 0.0001
Underweight 11.0 (5.4, 20.9) 60.7 (51.8, 68.9) 9.7 (6.1, 15.1) 11.8 (7.3, 18.6)
Normal weight 5.2 (3.3, 7.9) 46.8 (37.2, 56.7) 14.4 (10.6, 19.2) 12.1 (9.1, 15.9)
Overweight 8.3 (4.9, 13.5) 68.0 (52.4, 80.4) 25.5 (18.6, 33.9) 39.1 (29.7, 49.4)
Obesity 15.7 (8.7, 26.5) 60.2 (46.2, 72.7) 39.7 (28.8, 51.7) 60.2 (50.7, 69.1)
Minimum dietary diversity g 
(p-valuef) 0.09 0.51 0.12  < 0.05  < 0.05
Yes 8.7 (6.1, 12.3) 55.2 (47.4, 62.8) 21.9 (18.2, 26.2) 13.2 (10.6, 16.4) 25.3 (22.5, 28.4)
No 6.7 (4.3, 10.1) 52.6 (44.2, 60.9) 18.0 (14.3, 22.2) 7.1 (3.8, 12.7) 17.8 (13.9, 22.5)
Anemia h (p-valuef) 0.34  < 0.005 0.92 0.70 0.37
Yes 8.9 (5.2, 14.8) 59.2 (51.0, 66.8) 19.4 (14.7, 25.2) 11.4 (7.6, 16.8) 21.0 (17.5, 25.0)
No 6.7 (4.6, 9.6) 48.9 (41.8, 56.0) 19.7 (17.0, 22.7) 12.6 (9.8, 16.1) 24.1 (20.2, 28.4)
Iron deficiency I (p-valuef) 0.13  < 0.05 0.47 0.07 0.44
Yes 8.9 (5.7, 13.6) 58.4 (49.9, 66.4) 20.7 (15.8, 26.5) 8.7 (5.5, 13.3) 21.8 (18.5, 25.5)
No 6.9 (4.7, 9.8) 51.5 (44.7, 58.2) 18.8 (15.5, 22.6) 14.6 (10.9, 19.3) 23.7 (21.0, 26.6)
Iron deficiency anemia I (p-valuef) 0.20  < 0.005 0.86 0.23 0.08
Yes 9.8 (5.0, 18.4) 64.4 (54.0, 73.7) 20.1 (13.3, 29.0) 8.6 (4.5, 15.9) 18.4 (14.1, 23.7)
No 6.8 (5.0, 9.2) 50.0 (43.3, 56.7) 19.3 (16.3, 22.8) 12.9 (10.4, 15.9) 24.2 (21.6, 26.9)
Vitamin A insufficiency j (p-valuef) 0.93 0.71 0.50 0.14 0.99
Yes 7.5 (5.0, 11.2) 55.7 (48.9, 62.3) 22.0 (14.4, 32.3) 8.3 (4.3, 15.5) 22.9 (16.7, 30.6)
No 7.8 (4.8, 12.3) 53.9 (45.8, 61.8) 18.9 (15.4, 22.9) 13.2 (10.9, 15.9) 22.9 (20.1, 25.9)
Physically active (p-valuef) 0.95 0.06 0.09 0.87 0.80
Yes 8.3 (3.3, 19.0) 64.0 (55.0, 72.0) 15.8 (10.9, 22.2) 12.1 (6.0, 22.7) 21.8 (14.5, 31.3)
No 8.1 (5.6, 11.5) 53.3 (45.5, 60.9) 21.2 (18.2, 24.5) 11.4 (9.0, 14.3) 23.0 (20.7, 25.5)
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Inflammation. We found that inflammation was associated with a higher prevalence of obesity, hyperten-
sion and diabetes. Although not being part of the metabolic syndrome, inflammation is recognized as a central 
mechanism underlying its  pathophysiology27. There is growing evidence that chronic low-grade inflammation 
favors the development of insulin resistance and type 2  diabetes43–45. On the other hand, diabetes often leads to 
a dysfunctional immune system, with impaired immune response, rendering the individual more vulnerable to 
infection. Moreover, hyperglycemic states in diabetic and non-diabetic persons can negatively alter the outcome 
of  infections46,47. Consequently, diabetes is often associated with infectious diseases such as pneumonia, tubercu-
losis, HIV and particularly infections originating in the urinary  tract48 and increases the risk for morbidity and 
mortality from various infectious  diseases49. Thus, an increasing prevalence of diabetes might hamper the treat-
ment and control of certain infectious diseases in The  Gambia50. Moreover, human and animal studies indicate 
that inflammation causes  hypertension51.
Hypertension. According to the WHO, with an estimated 46% of adults older than 25 years of age affected, 
the prevalence of hypertension is highest in the African region; however, it is estimated that many cases remain 
undiagnosed because of weak health systems. A STEPwise WHO survey in 2010 in The Gambia estimated that 
26.1% of women 25–64  years of age were hypertensive, 71% of whom were  undiagnosed18. This estimate is 
higher than that found in this study, but this difference may be explained by the different age ranges of the 
two surveys. In 2010 the prevalence of hypertension was 16.9% and 33.6% in women aged 25–34 years and 
35–44 years, respectively, compared to 16.6% and 35.0% in 2018.
Limitations. Our study contains notable limitations. First, the cross-sectional nature of the data precludes 
any inference of causality. Second, as many of the cardiometabolic risk factors we investigated are interrelated, 
we generally do not imply the direction of the associations we  observe26,52. The sole exception are the well docu-
mented associations between obesity and other factors as noted above. Third, although WHO recommends the 
use of HbA1c to measure  diabetes53, we acknowledge that the high prevalence of anemia and/ or ID in Gambian 
women may have resulted in a small overestimation of the prevalence of diabetes and elevated HbA1c. Moreo-
ver, HbA1c thresholds vary by ethnic group; persons of African and Asian descent tend to have higher HbA1c 
levels compared to  Caucasians54–56. Hence, more research on HbA1c as a biomarker in different settings and the 
establishment of ethnic-specific cut-offs defining prediabetes and diabetes is warranted.
Conclusion
The high prevalence of cardiometabolic risk factors in non-pregnant women of reproductive age in The Gambia 
is of concern, particularly since a large proportion of women are affected by more than one risk factor. While 
obesity was identified as a risk factor of diabetes, elevated HbA1c, hypertension, and inflammation, large pro-
portions of the non-obese women also exhibited elevated HbA1c and/or hypertension and/or inflammation. 
Table 3.  Associations between different cardio metabolic risk factors in non-pregnant women, The Gambia, 
2018. a Diabetes defined as glycated hemoglobin (HbA1c) ≥ 6.5% and elevated HbA1c as HbA1c ≥ 5.7% 
b Hypertension defined as systolic blood pressure of ≥ 140 mmHg and/or a diastolic blood pressure 
of ≥ 90 mmHg c Obesity defined as body mass index (BMI) of ≥ 30 kg/m2, respectively d Percentages weighted 
for non-response and survey design e CI = confidence interval, adjusted for cluster and stratified sampling 
design f Chi-square p-value < 0.05 indicates that the proportion between the subgroups is statistically 
significantly k Any inflammation defined as CRP > 3 mg/L and/or AGP > 1 g/L
Characteristic
Diabetesa Elevated  HbA1ca Hypertensionb Obesityc Any  Inflammationk
(N = 1407) (N = 1407) (N = 1685) (N = 1651) (N = 1378)
%d (95% CI)e %d (95% CI)e %d (95% CI)e %d (95% CI)e %d (95% CI)e
Diabetesa (p-valuef) 0.73  < 0.005  < 0.05
Yes 20.4 (14.3, 28.3) 25.0 (15.9, 37.0) 34.2 (22.5, 48.1)
No 18.9 (15.4, 22.9) 11.4 (8.7, 14.6) 21.9 (20, 24)
Elevated HbA1ca (p-valuef) 0.89 0.24 0.08
Yes 19.2 (15.0, 24.1) 13.8 (11.0, 17.3) 25.1 (21.6, 28.9)
No 18.8 (15.1, 23.2) 10.9 (7.2, 16.0) 20.2 (17.4, 23.4)
Hypertensionb (p-valuef) 0.73 0.89  < 0.0001  < 0.0001
Yes 8.4 (4.3, 15.9) 54.8 (44.3, 64.9) 24.6 (16.4, 35.2) 38.7 (32.5, 45.3)
No 7.7 (5.6, 10.6) 54.2 (47.0, 44.3) 8.5 (6.7, 10.9) 19.1 (16.5, 21.9)
Obesityc (p-valuef)  < 0.005 0.24  < 0.0001  < 0.0001
Yes 15.7 (8.7, 26.5) 60.2 (46.2, 72.6) 39.7 (28.8, 51.8) 60.2 (50.7, 69.1)
No 6.7 (4.6, 9.7) 53.5 (46.6, 60.3) 15.8 (12.6, 19.7) 17.7 (15.5, 20.1)
Inflammationk (p-valuef)  < 0.05  < 0.08  < 0.0001  < 0.0001
Elevate CRP and/or AGP 11.5 (7.4, 17.4) 59.6 (49.5, 68.9) 32.9 (25.9, 40.9) 31.9 (25.5, 39.1)
No inflammation 6.6 (4.1, 10.2) 52.7 (46.2, 59.1) 15.5 (12.4, 19.2) 6.2 (4.3, 8.8)
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Model and characteristic Category Adjusted relative  riska 95% CI P-value
Diabetes model (n = 1,402)
Nutritional status
Underweight 1.39 (0.87, 2.22) 0.170
Normal Referent
Overweight 1.97 (1.31, 2.95) < 0.01
Obese 2.40 (1.56, 3.71) < 0.001
Sanitation
Adequate Referent
Not adequate 1.67 (1.17, 2.34) < 0.01
Elevated HbA1c model (n = 1,358)
Educational attendance
Never attended school Referent
Primary school 0.95 (0.82, 1.09) 0.435
Lower Secondary School 0.83 (0.72, 0.96) < 0.05
Upper Secondary School 0.84 (0.72, 0.98) < 0.05
Higher 0.94 (0.76, 1.16) 0.560
Nutritional Status
Underweight 1.11 (0.97, 1.28) 0.135
Normal Referent
Overweight 1.21 (1.07, 1.38) < 0.01
Obese 1.31 (1.14, 1.51) < 0.001
Iron deficiency
No Referent
Yes 1.20 (1.09, 1.33) < 0.001
Hypertension model (n = 1,358)
Age Group (years)
15–19 Referent
20–24 1.17 (0.74, 1.84) 0.502
25–29 1.20 (0.75, 1.92) 0.435
30–34 1.79 (1.16, 2.76) < 0.01
35–39 2.13 (1.40, 3.23) < 0.001
40–44 2.70 (1.76, 4.14) < 0.001
45–49 2.91 (1.90, 4.44) < 0.001
Educational attendance
Never attended school Referent
Primary school 0.89 (0.67, 1.19) 0.426
Lower Secondary School 0.83 (0.62, 1.11) 0.219
Upper Secondary School 0.64 (0.44, 0.94) 0.022
Higher 0.58 (0.34, 0.99) < 0.05
Inflammation
No Referent
Yes 1.42 (1.14, 1.78) < 0.01
Nutritional Status
Underweight 1.07 (0.75, 1.52) 0.707
Normal Referent
Overweight 1.22 (0.93, 1.60) 0.151
Obese 1.84 (1.40, 2.41) < 0.001
Obesity model (n = 1,640)
Age Group (years)
15–19 Referent
20–24 2.33 (0.99, 5.47) 0.052
25–29 2.94 (1.28, 6.79) < 0.05
30–34 10.36 (4.96, 21.64) < 0.001
35–39 7.99 (3.78, 16.90) < 0.001
40–44 13.64 (6.45, 28.84) < 0.001
45–49 10.86 (5.04, 23.40) < 0.001
Wealth quintile
Lowest Referent
Second 1.82 (1.03, 3.21) < 0.05
Middle 2.33 (1.36, 4.01) < 0.01
Fourth 3.72 (2.17, 6.35) < 0.001
Highest 3.93 (2.39, 6.48) < 0.001
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Hence, more research on drivers of cardiometabolic risk factors is warranted to formulate multiple strategies 
for their containment.
Methods
Survey design and participants. The Gambia National Micronutrient Survey was conducted between 
13th March and 4th May 2018. This was a nationwide cross-sectional stratified survey based on a probability 
sample to produce estimates with acceptable precision for priority indicators of nutritional status and nutri-
tion-related non-communicable diseases in non-pregnant women of reproductive age. The sample was drawn 
separately from the urban and rural areas in each of the eight Local Government Areas, resulting in 14 strata 
(the local government areas of Banjul and Kanifing had no rural strata because they are entirely urban). A two-
stage sampling procedure was used. The list of census enumeration areas selected as primary sampling units 
for the 2018 Multi Indicator Cluster Survey (MICS) served as sampling frame for the first stage of sampling. At 
this first stage of sampling for The Gambia National Micronutrient Survey 2018, MICS-selected primary sam-
pling units within each stratum were randomly selected with equal probability from the 390 enumeration areas 
enrolled in the MICS. In the 2nd stage of sampling, because household sizes vary by region, different numbers 
of households, which already participated in the MICS, were selected within each selected primary sampling 
 unit16; selection of households within a primary sampling unit were selected using simple random sampling 
from updated household lists. All non-pregnant women 15–49 years of age, pregnant women any age and chil-
dren 0–59 months of age living in the selected households were included in the survey. All non-pregnant women 
who participated in the Gambia National Micronutrient survey and with data on at least one of the investigated 
cardiometabolic risk factor were included in this study.
Data collection. Prior to data collection, experienced field workers received intense training as described 
 elsewhere16. First, oral consent was obtained and a short household questionnaire was administered to the head 
of the household. After obtaining written informed consent from each recruited woman, short questionnaires 
were administered. Anthropometric measurements were done using a medical scale (SECA, Hamburg, Ger-
many) and a standard wooden height board (UNICEF, Copenhagen, Denmark); and blood was collected as 
previously  described16.
Diagnostic tests and clinical thresholds. The study assessed the following cardiometabolic risk factors: 
Pre-diabetes, diabetes, hypertension, obesity and inflammation.
HbA1c concentration was used to assess the presence of diabetes and pre-diabetes. Diabetes was defined as 
HbA1c ≥ 6.5% and pre-diabetes as HbA1c ≥ 5.7% to < 6.5%, whereas elevated HbA1c was defined as ≥ 5.7%57. 
HbA1c was measured by using the Hemocue® HbA1c 501 (HemoCue, Ångelholm, Sweden). While this device 
was developed as a point-of-care device, we used it in field settings by powering the device with rechargeable 
battery packs. Quality control of the device was done using the “daily” and “monthly” check cartridges delivered 
with the device. In addition, daily quality control was done using control blood furnished by the instrument 
manufacturer which had two different HbA1c concentrations (range 7.1–8.3% and range 8.8–10.2%). Control 
blood was kept refrigerated at 2–8 °C for the duration of the field work to prevent degradation.
Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or a diastolic blood pressure 
of ≥ 90  mmHg58. Blood pressure was measured once on the left arm of each woman while the woman was sitting 
using an automatic blood pressure monitor (OMRON M300, Kyoto, Japan).
Chronic energy deficiency and overnutrition were assessed using the body mass index (BMI; kg/m2). Cut-
off points for BMI were as follows: < 16.0 severe chronic energy deficiency; 16.0–16.9 moderate chronic energy 
deficiency; 17.0–18.4 at-risk for energy deficiency; 18.5–24.9 normal; 25.0–29.9 overweight; ≥ 30.0 obese 59.
Table 4.  Adjusted relative risk of diabetes, hypertension, obesity in non-pregnant women, The Gambia, 2018. 
a Calculated using relative risk from Poisson regression.
Model and characteristic Category Adjusted relative  riska 95% CI P-value
Age group (years)
15–19 Referent
20–24 1.05 (0.70, 1.56) 0.815
25–29 1.22 (0.83, 1.81) 0.312
30–34 1.46 (1.02, 2.09) < 0.05
35–39 1.87 (1.31, 2.66) < 0.01
40–44 1.86 (1.28, 2.71) < 0.01
45–49 1.95 (1.32, 2.89) < 0.01
Nutrition status
Underweight 0.94 (0.64, 1.37) 0.735
Normal Referent
Overweight 2.03 (1.59, 2.60)  < 0.001
Obese 3.28 (2.60, 4.15)  < 0.001
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Inflammation was defined as AGP > 1 g/L60 or CRP > 3 mg/L61. Using the aforementioned cut-off values, each 
individual was assigned to one of the following four inflammation categories: elevated CRP only, elevated CRP 
and AGP, elevated AGP only, and no inflammation.
Women were considered anemic if hemoglobin concentrations were < 120 g/L66. ID and vitamin A insuffi-
ciency were defined as ferritin concentrations < 15 µg/L62 and RBP concentrations < 1.05 µmol/L63, respectively. 
Ferritin concentrations were adjusted for inflammation using CRP and  AGP64.
Hemoglobin concentrations were measured on-site using a portable haemoglobinometer (Hb 301 + Analyser, 
HemoCue® AB, Ängelholm, Sweden). Daily quality control was done using control blood furnished by the instru-
ment manufacturer (low, medium and high concentration).
Capillary blood samples (400–500 µl) were collected from a fingerprint into Microvette® tubes, and kept 
between 4 and 8 °C until they were centrifuged, after which serum was aliquoted and frozen at − 20 °C. Serum 
samples were subsequently stored in Banjul at − 280 °C and were shipped to the VitMin Laboratory in Germany 
for analysis of concentrations of C-reactive protein (CRP), alpha-1-acid glycoprotein (AGP), ferritin, and retinol 
binding protein (RBP) using the sandwich ELISA  approach65.
Data management and statistical analysis. Data were collected in the field using tablet computers and 
entered into an application built using CSPro version 7, with rigorous consistency checks after collection. Data 
analysis was done using Stata/IC version 14.2 (STATACorp, College Station, Texas, USA). Statistical weights 
were applied to all data to account for the unequal probability of selection in the 14 strata. For categorical vari-
ables, proportions were calculated to derive the prevalence of the different outcomes. The statistical precisions 
of prevalence estimates were assessed by using 95% confidence intervals. All measures of precision, including 
confidence limits and chi square p values for differences, were calculated accounting for the complex cluster and 
stratified sampling used in the  survey16.
Descriptive statistics were calculated across all strata together, for each stratum separately, and by age group. 
Factors associated with obesity, hypertension, elevated HbA1c, diabetes mellitus, and inflammation were iden-
tified using bivariate analyses. Variables with associations at p < 0.1 in the bivariate analyses were included in 
the respective multivariate models. During the construction of the multivariate models, backwards elimination 
was used to construct parsimonious models that only contained statistically significant (i.e. p < 0.05) covariates.
The Poisson  regression67, which yields adjusted risk ratios (aRRs), was considered superior to regression 
models that yield odds ratios (e.g. logistic regression), as the relatively high prevalence of all outcome variables 
examined in our analysis violated the rare disease  assumption68.
Ethics approval and consent to participate. Ethical approval for the survey (R18014) was obtained 
from The Gambia Government/MRC Joint Ethics Committee and the School of Medicine and Allied Health Sci-
ences Research & Publication Committee. The survey was conducted in accordance with the approved protocol.
Oral consent was obtained for household interviews from the household head or other knowledgeable house-
hold member. Written informed consent was obtained from selected women who were at least 18 years of age. 
For women younger than 18 years, written informed consent was sought from a parent or legal guardian. If any 
consenting survey participants were unable to read and write, the consent form was read out loud to them and 
a fingerprint was taken in lieu of a signature, or the respondent could assign a witness to sign on her behalf. 
Survey respondents diagnosed with severe anemia and/ or severe acute malnutrition were referred to the local 
health facility for further diagnosis and treatment.
Data availability
The data that support the findings of this study are available from The Gambia’s National Nutrition Agency 
(NaNA), but restrictions apply to the availability of these data, which were used with the permission of NaNA, 
and so are not publicly available. Data are however available from the authors upon reasonable request and with 
permission of NaNA.
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